PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
October 18, 2012Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology

Neuroleptic Malignant Syndrome During the use of Extended Release Quetiapine: A Case Report

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does extended release quetiapine cause neuroleptic malignant syndrome in a patient with atypical psychotic disorder?

Population

50-year-old woman diagnosed with atypical psychotic disorder for 5 years

Design

Case_report

Key result

Extended release quetiapine use was associated with the development of Neuroleptic Malignant Syndrome in a 50-year-old woman with atypical psychotic disorder.

Authors

FAFatma AkyüzSOSerap OflazCÜCemal Üstün

Discussion

Loading...

Member takes

Overview

Potential NMS with extended-release quetiapine warrants vigilance; single case leaves open causality and broader risk.

Study Design

Type

Case Report (n=1)

Structured PICO

Does extended release quetiapine cause neuroleptic malignant syndrome in a patient with atypical psychotic disorder?

P
Population
A 50-year-old woman with a 5-year history of atypical psychotic disorder who developed Neuroleptic Malignant Syndrome during the use of extended release quetiapine.
E
Exposure
Extended release quetiapine
O
Outcome
Development of Neuroleptic Malignant Syndrome (NMS)safety

Extended-release quetiapine can rarely cause life-threatening neuroleptic malignant syndrome.

Cite This Study

Akyüz et al. (2012) conducted a case report in Neuroleptic Malignant Syndrome (n=1). Extended release quetiapine was evaluated on Neuroleptic Malignant Syndrome. Extended release quetiapine use was associated with the development of Neuroleptic Malignant Syndrome in a 50-year-old woman with atypical psychotic disorder.

synapsesocial.com/papers/6a9cacece4895faeb35d3576https://doi.org/10.5455/bcp.20120731061958
View Full Paper
Ask AI
Bookmark
Share